Clinical Trials Directory

Trials / Completed

CompletedNCT00078130

Buprenorphine/Naloxone - Facilitated Rehabilitation for Opioid Dependent Adolescents - 1

Bup/Nx - Facilitated Rehab for Opioid Dependent Adolescents

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
223 (planned)
Sponsor
University of Pennsylvania · Academic / Other
Sex
All
Age
14 Years – 21 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare two 3-month treatments for adolescents/young adults who are addicted to heroin: buprenorphine/naloxone combined with psychosocial therapy and treatment as usual, a 7-14 day detoxification with buprenorphine and three weeks of psychosocial therapy.

Conditions

Interventions

TypeNameDescription
DRUGBuprenorphine/naloxone

Timeline

Start date
2003-07-01
Primary completion
2006-01-01
Completion
2006-01-01
First posted
2004-02-20
Last updated
2017-01-12

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00078130. Inclusion in this directory is not an endorsement.